Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice for "MicroRNA-133b-5p Is Involved in Cardioprotection of Morphine Preconditioning in Rat Cardiomyocytes by Targeting Fas" [Canadian Journal of Cardiology, Volume 32, Issue 8, August 2016, Pages 996-1007. doi:10.1016/j.cjca.2015.10.019].

The Canadian journal of cardiology·2026
Same author

Ciprofol pharmacology and dosing in various populations.

Expert opinion on pharmacotherapy·2025
Same author

Total intravenous anaesthesia in emergency surgery: a narrative review.

Anaesthesia·2025
Same author

Single-Syringe Total Intravenous Anesthesia: Dosing Concerns.

Anesthesia and analgesia·2025
Same author

Remimazolam - drug evaluations: expert opinion on pharmacotherapy.

Expert opinion on pharmacotherapy·2025
Same author

Expanding the role of intranasal dexmedetomidine in peri-operative care.

Anaesthesia·2025
Same journal

CORRIGENDUM TO: Recent advances in the diagnosis and management of pre-eclampsia.

F1000prime reports·2015
Same journal

Ethylene receptors in plants - why so much complexity?

F1000prime reports·2015
Same journal

Hematopoietic transcription factor mutations and inherited platelet dysfunction.

F1000prime reports·2015
Same journal

Advancing our knowledge of the complexity and management of intimate partner violence and co-occurring mental health and substance abuse problems in women.

F1000prime reports·2015
Same journal

Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.

F1000prime reports·2015
Same journal

Insomnia and sleep apnea in midlife women: prevalence and consequences to health and functioning.

F1000prime reports·2015
See all related articles

Related Experiment Video

Updated: May 13, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Perioperative cardioprotection.

May Km Leung1, Michael G Irwin

  • 1Department of Anaesthesiology, University of Hong Kong / Queen Mary Hospital Hong Kong SAR, China.

F1000Prime Reports
|March 21, 2013
PubMed
Summary
This summary is machine-generated.

Perioperative cardiac complications are a major risk during non-cardiac surgery, especially with high cardiovascular disease prevalence. Aspirin and statins are strongly recommended to reduce this risk, while beta-blockers require careful titration for high-risk patients.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Experiment Videos

Last Updated: May 13, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Area of Science:

  • Anesthesiology and Perioperative Medicine
  • Cardiology
  • Pharmacology

Background:

  • Non-cardiovascular surgery carries significant perioperative cardiac risks, contributing to morbidity and mortality.
  • The rising prevalence of cardiovascular disease exacerbates these risks.
  • Anesthesia is generally safe, but managing cardiac complications remains critical.

Purpose of the Study:

  • To review pharmacological strategies for mitigating perioperative cardiac complications during non-cardiovascular surgery.
  • To highlight evidence-based recommendations for medication use in at-risk surgical patients.

Main Methods:

  • Review of current evidence and clinical guidelines.
  • Analysis of pharmacological interventions for perioperative cardiac risk reduction.

Main Results:

  • Aspirin and statins are strongly supported by current evidence for reducing perioperative cardiac risk.
  • Beta-blockers may offer benefits in higher-risk populations but require careful titration and consideration of adverse effects.

Conclusions:

  • Pharmacological interventions, particularly aspirin and statins, can significantly reduce perioperative cardiac complications.
  • Careful patient selection and drug management, including beta-blockers, are essential for optimizing outcomes in high-risk surgical patients.